# Comparing the Effect of Metformin vs. Pep2dia as an Adjunct to Letrozole on Ovulation Induction and Pregnancy Outcomes in Overweight Women With PCOS

> **NCT06452511** · EARLY_PHASE1 · COMPLETED · sponsor: **Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy** · enrollment: 100 (actual)

## Conditions studied

- PCOS

## Interventions

- **DRUG:** Metformin
- **DRUG:** pep2dia

## Key facts

- **NCT ID:** NCT06452511
- **Lead sponsor:** Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-01
- **Primary completion:** 2025-03-25
- **Final completion:** 2025-03-25
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06452511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06452511, "Comparing the Effect of Metformin vs. Pep2dia as an Adjunct to Letrozole on Ovulation Induction and Pregnancy Outcomes in Overweight Women With PCOS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06452511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*